BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2801138)

  • 21. [Anti-arrhythmia properties of marcaine].
    Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
    Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-arrhythmic effects of sophoridine and oxysophoridine.
    Zhang HM; Li HQ
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):517-20. PubMed ID: 10678144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of guan-fu base a on experimental cardiac arrhythmias and myocardial contractility].
    Dong YL; Chen WZ
    Yao Xue Xue Bao; 1995; 30(8):577-82. PubMed ID: 8571777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible antiarrhythmic activities of trapidil.
    Sakanashi M; Yoshikawa Y; Akiyoshi R; Itoh C; Kitamura Y; Niho T; Ohnishi H
    Arzneimittelforschung; 1983; 33(2):215-7. PubMed ID: 6682660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on a new antiarrhythmic drug changrolin-4-(3',5'-bis [(N-pyrrolidinyl) methyl]-4'-hydroxyanilino)-quinazoline.
    Li LQ; Qu ZX; Wang ZM; Zeng YL; Ding GS; Hu GJ; Yang XY
    Sci Sin; 1979 Oct; 22(10):1220-8. PubMed ID: 515728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of sodium 18 beta-glycyrrhetate on experimental arrhythmia].
    Li X; Wu Y; Guo Z; Liu L
    Zhongguo Zhong Yao Za Zhi; 1992 Mar; 17(3):176-8, inside backcover. PubMed ID: 1418542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of liensinine on haemodynamics in rats and the physiologic properties of isolated rabbit atria].
    Wang JL; Nong Y; Jing MX
    Yao Xue Xue Bao; 1992; 27(12):881-5. PubMed ID: 1299135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronotropic and inotropic effects on atria of chronic ethanol ingestion in the aging rat.
    Posner P; Baker SP; Hunter B; Walker DW
    Alcohol Drug Res; 1987; 7(4):273-7. PubMed ID: 3828003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
    Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
    Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental electrocardiography research. A study in the rat of the cardiovascular effects of verapamil].
    Valora N; Bruno C; Floridi S; Mei V; Pranzetti P; Cherchi GM
    Boll Soc Ital Biol Sper; 1981 Jun; 57(12):1352-8. PubMed ID: 7295406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiarrhythmic activity of alaglyzin].
    Bryzgalov AO; Volkova EB; Ganenko IuA; Dolgikh MP; Zhukova NA; Sorokina IV; Tolstikova TG
    Eksp Klin Farmakol; 2005; 68(4):24-7. PubMed ID: 16193652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propranolol analog with the natural monoterpene structure as a potent antiarrhythmic drug.
    Librowski T; Filipek B; Czarnecki R; Beresewicz A; Karwatowska-Prokopczuk E
    Acta Pol Pharm; 1998; 55(3):243-7. PubMed ID: 9735705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of berbamine hydrochloride on experimentally-induced arrhythmias].
    Yang BF; Wang XH; Li Y; Li WH
    Yao Xue Xue Bao; 1987 Sep; 22(9):700-3. PubMed ID: 2833064
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of magnesium on isolated rabbit atria.
    Hammad D; Omar SA; Varma S
    Indian J Physiol Pharmacol; 1981; 25(2):123-30. PubMed ID: 7287134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cycloprotobuxine-A on atrial fibrillation.
    Wang YX; Zheng YM; Tan YH; Sheng BH
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):245-50. PubMed ID: 10072943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.